Tetracycline controlled gene expression systems have become powerful tools in the analysis of gene function in mammalian cell culture as well as transgenic animals and plants. The original description of a tetracyclineregulated gene expression system is based on two plasmids, one of which constitutively expresses a tetracycline-controlled transactivator protein (tTA), a fusion protein between the tetracycline repressor of E. coli and the transcriptional activation domain of the VP16 protein of herpes simplex virus. The second plasmid contains the gene to be regulated by tTA under the control of an inducible promoter which consists of seven copies of the tetracycline resistance operator (tetO). Since this original description, many modi®ca-tions have been described. In this report, we evaluate an autoregulatory tetracycline controlled system, in which the tTA is itself under the control of the tetO. We demonstrate that this autoregulatory tetracycline system produces adverse eects including cellular morphologic changes, growth rate attenuation and alterations in cell cycle distribution.
Introduction
Attempts to elucidate a gene's cellular function(s) have led to the development of several dierent inducible systems. Many of these inducible systems, such as those utilizing metallothionein promoters, heat shock promoters, or steroid response elements, have encountered limitations including low induction levels, toxic or other nonspeci®c eects of the inducing agents, and/or basal leakiness. An inducible system, based on the regulatory elements of the Tn10-speci®c tetracycline-resistance operon of E. coli, has been described by Gossen and Bujard (1992) . This tetracycline system overcomes many of the limitations of the previous inducible systems and has been widely used in mammalian cell culture (Bergman et al., 1995; Buckbinder et al., 1994; Chen et al., 1995; Lukas et al., 1996; Maheswaran et al., 1995; Resnitzky et al., 1994; Reynisdottir et al., 1995; Shan and Lee, 1994; Sheikh et al., 1997; Wimmel et al., 1994) , transgenic animals (Fishman et al., 1994; Furth et al., 1994) , and transgenic plants (Gil and Green, 1996; Masgrau et al., 1997; Weinmann et al., 1994) .
The original tetracycline regulated system is based on the presence of two plasmids (Figure 1a ) (Gossen and Bujard, 1992) . The ®rst plasmid constitutively expresses a tetracycline-controlled transactivator (tTA) protein which is a fusion protein of the E. coli tetracycline repressor DNA-binding domain and the transcriptional activation domain of the herpes simplex virus protein VP16. The second plasmid contains the target gene under the control of seven copies of the tetracycline operator (tetO). In the absence of tetracycline, tTA binds to the tetO, and transcription of the target gene is subsequently activated. In the presence of tetracycline, a conformational change in the tetracycline repressor prevents the tTA from binding DNA, thus silencing the promoter.
Since the original description of this system, several modi®cations have been made (Baron et al., 1995; Hofmann et al., 1996; Iida et al., 1996; Schultze et al., 1996; Shockett et al., 1995) . One such modi®cation involves placing the tTA gene under the control of a promoter containing the tetO (pTetTAk), instead of the constitutively active CMV promoter, thus creating an autoregulatory tTA expression vector (Figure 1b ) (Shockett et al., 1995) . In this autoregulatory system, tetracycline blocks the tTA from binding the tetO preventing expression of both the tTA and the target gene. When tetracycline is removed, however, small amounts of tTA present within the cell will bind to the tetO and stimulate expression of both the tTA as well as the target gene. Because tTA is now produced in a positive feedback loop, higher levels of the target gene are generated. Postulated advantages of this system include the reduction of possible toxic eects of the tetracycline transactivator in the uninduced state as well as higher levels of inducible gene expression (Shockett et al., 1995) . However, once tetracycline is removed, a positive feedback loop is initiated within the cell leading to continuously increasing levels of tTA. Moreover, once tetracycline is removed two genes are now induced, tTA and the target gene. The induced expression of tTA, along with the target gene, potentially complicates such a system, especially since the VP16 region of the tTA is postulated to have toxic cellular eects (Gossen and Bujard, 1992) . We have thus evaluated this autoregulatory tetracyclineregulated tTA system in a cell culture system by examining cell clones which contain only the inducible tTA. Here we show that induction of tTA produces adverse cellular eects including morphologic changes, growth rate attenuation, and alterations in cell cycle distribution.
Results and discussion
To generate stable cell lines containing an inducible tTA, the hamster glioblastoma cell line HJC-15 was transfected with the autoregulatory inducible tetracycline-controlled transactivator plasmid, pTetTAk. Stable cell lines were isolated by resistance to the antibiotic G418. To prevent the expression of tTA, cells were continuously maintained in the presence of tetracycline. Since pTetTAk was reported to produce cell clones with higher inducible activity than cell lines produced with the constitutive tetracycline-controlled transactivator (Shockett et al., 1995) , we chose to verify whether our stable pTetTAk clones contain a functionally active tTA by Western blot analysis. To this end, the stable pTetTAk cell lines were transiently transfected with a tetracycline regulated plasmid containing a target gene, grown in the presence or absence of tetracycline, and analysed by Western blot analysis using an antibody which recognizes the target protein. Seven out of seventy stable pTetTAk cell lines analysed using this transient assay demonstrated inducible levels of the target protein by Western blot analysis (data not shown) indicating that these seven clones contain a functional and inducible tTA. Since tTA is postulated to have deleterious cellular eects (Gossen and Bujard, 1992) and since upon removal of tetracycline we are initiating a positive feedback loop generating continuously increasing levels of tTA, we further analysed several pTetTAk clones.
To ®rst con®rm that our pTetTAk cell lines contained an inducible tTA, we analysed four pTetTAk clones by Northern blot analysis using a probe for tTAk mRNA. Figure 2a demonstrates that mRNA corresponding to the tTAk gene is detected in the four cell clones induced for 48 h after tetracycline removal (lanes 2, 4, 6 and 8), but not in the uninduced state (lanes 3, 5, 7 and 9) nor in the control HJC cells (lane 1). Since message levels do not always correlate with protein levels, we also examined the levels of the tTA protein by Western blot analysis. Figure 2c shows that the tTA protein is detectable by Western blot analysis in cell clones induced for 48 h after tetracycline removal (lanes 2, 4, 6 and 8). The tTA is undetectable in the control HJC cells (lane 1) and in clone 1-1 in the uninduced state (lane 3). A low level of tTA is detectable in clones 3-3, D-5, and E-5 in the uninduced state (lanes 5, 7 and 9, respectively). These results demonstrate that our stable pTetTAk cell lines do contain an inducible tTA. We next analysed several characteristics of these cell lines. The parameters we chose to characterize included cellular morphology, growth rates and cell cycle distribution.
The morphology of cells upon tTA induction was examined microscopically. Figure 3 shows a time course of the cell line D-5 in the presence and absence of tetracycline. Upon tetracycline removal, the cells remain unaltered at time points before 48 h. At time points longer than 48 h, however, several morphologic changes begin to occur. The cells in which tTA is induced are swollen compared to the uninduced state ( Figure 3 , compare e and g with f and h, respectively). Perhaps even more notable is the emergence of cells with a binucleate appearance in the tTA-induced cell populations (Figure 3f and h). At later time points, cells with the appearance of more than two nuclei are observed. These morphological changes were apparent in other tTA-inducible cell lines (data not shown). These data demonstrate that the induction of tTA is accompanied by cellular morphologic changes.
Since the induction of tTA results in cellular morphologic changes, we investigated the eect of tTA induction on cellular growth rates by examining growth curves of tTA cell lines in the presence and absence of tetracycline. The growth rates of two clones are shown in Figure 4 . The growth rates of clones 3-3 (Figure 4a ) and D-5 ( Figure 4b ) were decreased upon induction of tTA. A decrease in cell growth of approximately 50% and 70% was observed at 96 h for clones 3-3 and D-5, respectively. Other tTA inducible cell lines demonstrated similar growth rate eects upon the induction of tTA (data not shown). These data demonstrate that in addition to the cellular morphologic changes observed, induction of tTA is also accompanied by cellular growth rate attenuation.
In an attempt to explain this growth inhibiting eect, we chose to analyse the cell cycle distribution of our cell populations in the presence and absence of tetracycline by¯uorescence-activated cell sorter (FACS) analysis. Flow cytometric analysis of the tTA inducing clonal cell line D-5 indicated that induction of tTA was associated with an increase in the percentage of cells in the G1 phase of the cell cycle (Figure 5a ). This increase in G1 was evident at the earliest time point examined, 12 h after induction. This increase also remained throughout the length of the time course and ranged from 10 ± 15% greater than the uninduced state. Concomittant with the increase in the G1 phase of the cell cycle, induction of tTA in clone D-5 was also associated with a decrease in the percentage of cells in the S phase of the cell cycle (Figure 5b ). Similar to the characteristics of the change in the G1 phase of the cell 
FACS analysis of other tTA inducible cell lines produced similar results (data not shown).
In the original description by Gossen and Bujard (1992) , the level of tTA was only detected by a sensitive gel shift assay. One explanation postulated to account for this low tTA level is the potential adverse eects of the VP16 portion of the tTA (Gossen and Bujard, 1992) . In fact, Shockett et al. (1995) suggested that an inducible tTA would avoid this problem and subsequently generate cell clones with a much higher level of inducibility. In this system, however, since the tTA is itself under control of the tetO, the absence of tetracycline generates a positive feedback system producing ever increasing levels of tTA. We examined this autoregulatory tetracycline-controlled transactivator plasmid in a hamster glioblastoma cell line and found that the positive feedback loop generating tTA results in cellular morphologic changes, growth rate attenuation, and alterations in cell cycle distribution.
In a recent study investigating the eects of E2F on the cell cycle, the original tetVP16 plasmid was used as a control for nonspeci®c eects of over-expression of a transcriptional activator within the cell (Qin and Barsoum, 1997) . In this study, cells transfected with tetVP16 exhibited no alterations in the cell cycle. Although no deleterious eects on the cell cycle were observed, it is noteworthy that the expression of the VP16 used in this study was under the control of the constitutively active CMV promoter. Perhaps it is only when higher levels of VP16 are produced as in the positive feedback loop present with pTetTAk, that cell cycle alterations are generated.
In the initial description of this autoregulatory tetracycline-regulated system, Shockett et al. (1995) utilize cell culture assays whose duration of length is 48 h or less. The authors do note greater than 50% cell death within 10 days and a loss of detectable tTA protein by 16 days after induction of tTA. These results are consistent with our ®ndings in so far as we do not observe any morphologic or growth rate changes within the ®rst 48 h after tTA induction. We did, however, detect cell cycle alterations at the ®rst time point examined, 12 h after tTA induction. Shockett et al. (1995) also generated transgenic mice with pTetTAk and a ptet-luciferase construct and demonstrate induced luciferase activity in many mouse tissues. The authors speculate that the potential toxicity of tTA may not be a serious problem in vivo. Although we did not conduct in vivo experiments, our in vitro data demonstrates that induction of tTA is associated with several adverse cellular responses which may complicate the interpretation of data based on such a system.
Materials and methods

Plasmids and cell lines
The autoregulatory inducible tetracycline transactivator system was purchased from GIBCO Life Technologies. HJC-15 cells (London et al., 1978) were maintained in Dulbecco's modi®ed Eagle's medium supplemented with 10% fetal calf serum (FCS), 100 units/ml of penicillin and 100 mg/ml of streptomycin. The plasmid pTetTAk was transfected into 10 cm plates of HJL-15 cells via calcium phosphate precipitation (Graham and van der Eb, 1973). Individual cell clones were selected in the presence of 1 mg/ ml of G418 (Geneticin; GIBCO). To prevent expression of tTA, cells were continuously maintained in the presence of 2 mg/ml of tetracycline (Sigma). These stable pTetTAk cell lines were tested for their ability to induce expression from a tetracycline regulated promoter by transient transfection followed by Western blot analysis. For all experiments, stable pTetTAk cell lines were plated in the presence of 500 mg/ml of G418 and 2 mg/ml of tetracycline. Twentyfour hours later, plates were washed three times with 16PBS and the cells were either maintained in medium containing 2 mg/ml of tetracycline or in medium without tetracycline.
RNA isolation and Northern blot analysis
Total RNA was isolated from stable pTetTAk cell lines using a hot phenol extraction (Queen and Baltimore, 1983) . Cells were washed twice with 16PBS and lysed with a solution containing 50 mM sodium acetate (pH 5.1) and 1% SDS. Cell lysates were scraped into tubes containing an equal volume of prewarmed acid phenol (equilibrated with 50 mM sodium acetate, (pH 5.1)) and incubated at 608C for 15 min. The aequous phase was extracted with neutral phenol/chloroform (equilibrated with 50 mM Tris, (pH 7.4)), followed by chloroform extraction and ethanol precipitation. For Northern blot analysis, 20 mg of total RNA was separated by electrophoresis in a 1.2% agarose, 0.4% formaldehyde, 16morpholinepropanesulfonic acid (MOPS) gel and transferred to a nylon membrane (Hybond N, Amersham) in 206 sodium chloride, sodium citrate (SSC). The RNA was UV-cross-linked to the membrane and then prehybridized at 428C for 4 h in 56SSC, 16Denhardt's solution, 0.5% sodium dodecyl sulfate (SDS), 50% deionized formamide, 300 mg/ml salmon sperm DNA, and 50 mg/ml tRNA. Hybridization was performed at 428C overnight with 10 6 c.p.m./ml of 32 Plabeled tTA probe. The EcoRI ± BamHI fragment of pUHD15-1 (Gossen and Bujard, 1992) containing the tTA open reading frame was labeled using a random hexamer labeling kit (Amersham). After hybridization, the membranes were washed twice with 26SSC and 0.1% SDS and once with 0.56SSC and 0.1% SDS at room temperature. Membranes were air dried and exposed to X-ray ®lm for 24 h at 7708C.
Preparation of cell extracts and Western blot (immunoblot) analysis
Cells were washed twice with 16PBS and lysed in buer containing 50 mM Tris-HCl (pH 7.4), 150 mM NaCl, 5 mM EDTA, 0.1% NP-40, 50 mM NaF, 1 mM PMSF and 1 mg/ml leupeptin. Lysates were scraped and collected into microfuge tubes, vortexed brie¯y, microcentrifuged for 20 min at 48C, and the supernatant stored at 7808C. Twenty mg of protein was separated by 10% SDS ± PAGE and transferred to supported nitrocellulose membranes (BIO-RAD). For Western blot analysis the anti tTA antibody was used at a 1 : 500 dilution and antibody detection was achieved by enhanced chemiluminescence (ECL) according to the manufacturer's protocol (Amersham).
Growth rate determination
Cells were seeded at 2.5610 4 cells per 10 cm plate. The following day, plates were washed three times with 16PBS and cells were maintained in medium containing 2 mg/ml of tetracycline or medium without tetracycline. At the indicated times, cells were trypsinized, stained with trypan blue, and counted with a hemacytometer. Cell viability was greater than 90% at each time point examined.
Fluorescence-activated cell sorter (FACS) analysis
Cells were trypsinized, ®xed in 70% ethanol and stored at 48C. Before FACS analysis, the cells were washed in 16PBS and resuspended in 16PBS containing 10 mg/ml of RNase A and 50 mg/ml of propidium iodide. Typically, 2610 4 cells per sample were analysed on a Coulter Epics XL¯ow cytometer and DNA distribution was measured with Multi-Cycle software (Phoenix Flow Systems).
